Showing results (1331-1340 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|November 20, 2014
Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 InhibitorsMd Jashim Uddin, Anna V Elleman, Kebreab Ghebreselasie, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer ImmunotherapyHongjun Zhang, Kun Liu, Qinglin Pu, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Synthesis and μ-Opioid Activity of the Primary Metabolites of CarfentanilFu-Lian Hsu, Andrew J Walz, James M Myslinski, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis ModelMaolin Yu, Mark W Ledeboer, Matthew Daniels, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor AntagonistDaniel D Long, Scott R Armstrong, David T Beattie, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload OptimizationAlexei S Karpov, Cristina M Nieto-Oberhuber, Tinya Abrams, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
A Curiously Linear Path to Academic Drug DiscoveryKathryn M Nelson
ACS Medicinal Chemistry Letters|March 19, 2020
A Medicinal Chemist's Journey at the National Institutes of Health One Molecule at a TimeAmy Hauck Newman
ACS Medicinal Chemistry Letters|March 19, 2020
Spotlight on AKT: Current Therapeutic ChallengesIna Landel, Lena Quambusch, Laura Depta, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Hsp70 and the Unfolded Protein Response as a Challenging Drug Target and an Inspiration for Probe Molecule DevelopmentLeila Terrab, Peter Wipf
Pageof 438